Results 91 to 100 of about 62,270 (271)

Pharmacogenetics of Bronchodilator Response: Future Directions

, 2021
Joanne E. Sordillo, Rachel S. Kelly, Sharon M. Lutz, Jessica Lasky‐Su, Ann Chen Wu   +4 more
openalex   +2 more sources

Natural History of Airway Hyperresponsiveness and Its Association With Asthma Traits

Allergy, EarlyView.
AHR improves in most children over adolescence when its relationship with asthma changes. AHR is better at ruling out asthma in children, while it is superior at ruling in asthma in young adults. Age should be considered when interpreting AHR, and different cutoffs might be required for children and adults.
Sophie Carra, Hongmei Zhang, Ramesh J. Kurukulaaratchy, Syed Hasan Arshad   +3 more
wiley   +1 more source

COPD and cardiovascular disease [PDF]

, 2019
COPD is one of the major public health problems in people aged 40 years or above. It is currently the 4th leading cause of death in the world and projected to be the 3rd leading cause of death by 2020.
André, S., Areias, Vanda, Boléo-Tomé, J.P., Cardoso, J., Conde, B., Fragoso, E.   +5 more
core   +3 more sources

Molecular IgE Sensitization Profiling With Micro‐Arrayed Allergen Molecules in Adult Patients With Asthma From the LEAD Cohort: A Precision Medicine Approach

Allergy, EarlyView.
In the LEAD cohort, micro‐arrayed asthma allergens identified IgE‐sensitized adult asthma patients. Compared to non‐IgE‐sensitized patients, they had better lung function, took less ICS and had lower eosinophils. IgE‐sensitized patients were sensitized to a handful of respiratory allergen sources and may benefit from allergen‐specific forms of ...
Huey‐Jy Huang, Robab Breyer‐Kohansal, Katarzyna Niespodziana, Charmaine J. M. Lim, Marie‐Kathrin Breyer, Rudolf Valenta, Sylvia Hartl, the Allergochip Working Group, Maria‐Roxana Buzan, Kuan‐Wei Chen, Monica Daniela Cotarcă, Alexandra Dubovets, Pia Gattinger, Alexander Karaulov, Evgenii Kozlov, Carmen Panaitescu, Daria Trifonova, Mikhail Tulaev, Susanne Vrtala, Milena Weber, Lauriana‐Eunice Zbîrcea   +20 more
wiley   +1 more source

Multi-omic approach associates blood methylome with bronchodilator drug response in pediatric asthma [PDF]

, 2023
Javier Pérez-García, Esther Herrera‐Luis, Annie Li, Angel C. Y. Mak, Scott Huntsman, Sam S. Oh, Jennifer R. Elhawary, Celeste Eng, Kenneth B. Beckman, Donglei Hu, Fabián Lorenzo-Díaz, Michael A. LeNoir, José Rodríguez‐Santana, Noah Zaitlen, Jesús Villar, Luisa N. Borrell, Esteban G. Burchard, Maria Pino‐Yanes   +17 more
openalex   +1 more source

Regional lung deflation with increased airway volume underlies the functional response to bronchodilators in chronic obstructive pulmonary disease

Physiological Reports, 2019
Bronchodilators, including long‐acting muscarinic antagonists (LAMAs), improve airflow limitation and lung hyperinflation in patients with chronic obstructive pulmonary disease (COPD).
Naoya Tanabe, Susumu Sato, Shigeo Muro, Hiroshi Shima, Tsuyoshi Oguma, Kazuya Tanimura, Atsuyasu Sato, Toyohiro Hirai   +7 more
doaj   +1 more source

The Potential Involvement of an ATP-Dependent Potassium Channel-Opening Mechanism in the Smooth Muscle Relaxant Properties of Tamarix dioica Roxb.

Biomolecules, 2019
Background: Tamarix dioica is traditionally used to manage various disorders related to smooth muscle in the gastrointestinal, respiratory, and cardiovascular systems.
Syeda Madiha Imtiaz, Ambreen Aleem, Fatima Saqib, Alexe Nicolae Ormenisan, Andrea Elena Neculau, Costin Vlad Anastasiu   +5 more
doaj   +1 more source

Effect of inspiratory pressure support on exercise performance in patients with chronic obstructive pulmonary disease [PDF]

, 2006
Title: Effect of inspiratory pressure support on exercise performance in patients with chronic obstructive pulmonary disease. Purpose: This study examined the effects of a non-invasive ventilator on submaximal and maximal exercise performance in ...
Doggett, Anita
core  

Predictors of Response to Biologics for Severe Asthma: A Systematic Review and Meta‐Analysis

Allergy, EarlyView.
ABSTRACT Biologics are effective for severe asthma, but not all patients benefit equally. There is an urgent need to understand which biologic works best for which patient. We systematically searched for predictors of response to biologics (except omalizumab) for severe asthma in four bibliographic databases and two trial registries from 1990 to 2024 ...
Anna Rattu, Piers Dixey, David Charles, Chris Brightling, Kian Fan Chung, Apostolos Bossios, Arnaud Bourdin, Ratko Djukanovic, Sven‐Erik Dahlén, Louise Fleming, Rekha Chaudhuri, Erik Melén, Antoine Deschildre, Charles Pilette, Gerard H. Koppelman, Andrew Exley, Freja Anckers, Sarah Miller, Hanna Nielsen, Clare Williams, Ekaterina Khaleva, Graham Roberts, on behalf of the 3TR consortium Respiratory Work Package   +22 more
wiley   +1 more source

Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study

International Journal of COPD, 2017
Takuya Samukawa,1,* Koichiro Matsumoto,2,* Go Tsukuya,1 Chihaya Koriyama,3 Satoru Fukuyama,2 Akifumi Uchida,1 Keiko Mizuno,1 Hironori Miyahara,4 Yutaka Kiyohara,5 Toshiharu Ninomiya,6 Hiromasa Inoue1 1Department of Pulmonary Medicine, Graduate School of
Samukawa T, Matsumoto K, Tsukuya G, Koriyama C, Fukuyama S, Uchida A, Mizuno K, Miyahara H, Kiyohara Y, Ninomiya T, Inoue H   +10 more
doaj